Elevated serum endocan levels correlate with cardiovascular risk in systemic lupus erythematosus, implying significant health concerns.
Elevated serum levels of endocan in SLE patients may be associated with subclinical atherosclerosis and endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Shintenawy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: